Renflexis 100 MG vials
Ended Awarded
- Contract number
- SPE2DB25FC0K7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $54,991
Award facts
- Contract value 100% obligated
- $54,991.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $54,991.09 to AmerisourceBergen Drug Corp for the supply of Renflexis 100 mg vials, with an ultimate completion date of May 1, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. This delivery order specifically procures Renflexis, a biosimilar infliximab product used to treat inflammatory conditions, fulfilling the Defense Logistics Agency's medical supply chain requirements for federal healthcare systems serving the Department of Defense, Defense Health Agency, U.S. Coast Guard, and other government entities. The delivery order reflects the company's established capability to meet federal procurement requirements through open competition and its critical role as a pharmaceutical prime vendor supporting military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FC0K7?
SPE2DB25FC0K7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 30, 2025.
How much is contract SPE2DB25FC0K7 worth?
The government has obligated $54,991 on SPE2DB25FC0K7.
Is contract SPE2DB25FC0K7 an order under another contract?
Yes. SPE2DB25FC0K7 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FC0K7 competed?
The extent of competition for SPE2DB25FC0K7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award